DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Pancreatitis - Pipeline Review, H2 2016" report to their offering.
'Pancreatitis - Pipeline Review, H2 2016'; Pancreatitis pipeline therapeutics constitutes close to 23 molecules. Out of which approximately 19 molecules are developed by Companies and remaining by the Universities
Institutes.
The report 'Pancreatitis - Pipeline Review, H2 2016' outlays comprehensive information on the therapeutics under development for Pancreatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
Pancreatitis is an inflammation of pancreas. Symptoms include upper abdominal pain, nausea, vomiting, and tenderness when touching the abdomen, weight loss and upper abdominal pain. Predisposing factors include alcoholism, smoking, family history of pancreatitis, infection, injury to the abdomen and pancreatic cancer. Treatment includes antibiotics and medication to relieve pain.
It also reviews of key players involved in therapeutic development for Pancreatitis and features dormant and discontinued projects. Currently, The molecules developed by Companies in Phase II, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 1, 13, 3 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 4 molecules, respectively.
Key Topics Covered:
- Introduction
- Pancreatitis Overview
- Therapeutics Development
- Pipeline Products for Pancreatitis - Overview
- Pipeline Products for Pancreatitis - Comparative Analysis
- Pancreatitis - Therapeutics under Development by Companies
- Pancreatitis - Therapeutics under Investigation by Universities/Institutes
- Pancreatitis Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Pancreatitis - Products under Development by Companies
- Pancreatitis - Products under Investigation by Universities/Institutes
- Pancreatitis - Companies Involved in Therapeutics Development
- Angion Biomedica Corp.
- Atox Bio Ltd.
- Bharat Serums And Vaccines Limited
- CalciMedica, Inc.
- Dynavax Technologies Corporation
- Generon (Shanghai) Corporation Ltd.
- GlaxoSmithKline Plc
- LipimetiX Development Inc
- Novartis AG
- Pharming Group N.V.
- Sun BioPharma, Inc.
For more information about this report visit http://www.researchandmarkets.com/research/5kpznj/pancreatitis